Effects of Repetitive Transcrannial Magnetic Stimulation on Non-Suicidal Self-Injury
1 other identifier
interventional
60
1 country
1
Brief Summary
Non-suicidal self-injury (NSSI) refers to a series of direct and consequently repeated injuries to one's body without suicidal intent. At present, it has become an important issue of mental disorders. This article focuses on the formation mechanism of NSSI and the intervention effect of rTMS on NSSI patients. At the same time, NSSI patients are collected, a treatment plan is designed to complete a two-week treatment, and the results are analyzed. The aim is to provide theoretical basis for the clinical diagnosis and treatment of NSSI, and also to provide reference for the clinical diagnosis and treatment of NSSI patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 30, 2024
CompletedFirst Submitted
Initial submission to the registry
July 10, 2024
CompletedFirst Posted
Study publicly available on registry
August 6, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2025
CompletedAugust 6, 2024
August 1, 2024
11 months
July 10, 2024
August 1, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Ottawa Self-injury Inventory
OSI was evaluated by professionally trained doctors (non experimental intervention) at baseline and two weeks after treatment to assess the effectiveness of the treatment. Comparing the differences in self harm thoughts and behaviors between the baseline period and the intervention group and the control group, p\<0.05 indicates a significant difference.
2 weeks
Magnetic resonance imaging
2 weeks
Study Arms (2)
Effects of rTMS on NSSI
EXPERIMENTALExploring the effectiveness of rTMS intervention in NSSI patients using the Ottawa Self Injury Scale and other scales as research subjects
rs-fMRI-functional connectivity
EXPERIMENTALBased on rs fMRI technology, imaging methods were used to analyze the brain images of patients and explore the changes in functional connectivity of brain regions before and after intervention in two groups of subjects.
Interventions
The stimulation site is the right IPL (EEG International 10-20 system, electrode CP4/CP6), with a stimulation frequency of 1-Hz and intensity of 100% RMT. There are 50 pulses each time, 20 seconds each cycle, 5 seconds each, with an interval of 15 seconds, for a total of 60 cycles, a total duration of 20 minutes, and a total of 3000 pulses. Perform treatment once a day, rest for 2 days after 5 consecutive days of treatment, for a total of 2 weeks, and receive 10 treatments.
Eligibility Criteria
You may qualify if:
- Meets the NSSI diagnostic criteria recommended in DSM-5;
- The Chinese version of the Brief International Neuropsychiatric Interview (MINI) screen for diagnostic compliance;
- Age :10-55 years old;
- Right hand;
- The paitent voluntarily participate and sign the informed consent form for this study (signed by participants under the age of 18 and their families);
- Able to understand written language and cooperate with questionnaire surveys.
You may not qualify if:
- History of severe substance abuse;
- The patient has other serious mental disorders, neurological disorders, or physical illnesses; 3、Previously experienced epileptic seizures;
- 、Pregnant or lactating women; 5、Contraindications to magnetic resonance imaging and transcranial magnetic stimulation; 6、Unable or refused to provide written informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nanjing Brain Hospital
Nanjing, Jiangsu, 210029, China
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate chief physician
Study Record Dates
First Submitted
July 10, 2024
First Posted
August 6, 2024
Study Start
June 30, 2024
Primary Completion
May 30, 2025
Study Completion
June 15, 2025
Last Updated
August 6, 2024
Record last verified: 2024-08